MARCH MEDICAL LIMITED

Dissolved Weybridge

Activities of head offices

0 employees website.com
Activities of head offices
M

MARCH MEDICAL LIMITED

Activities of head offices

Founded 23 Nov 2005 Dissolved Weybridge, England 0 employees website.com
Activities of head offices

Previous Company Names

CHARCO 1144 LIMITED 23 Nov 2005 — 17 Jan 2006
Accounts Submitted 14 Aug 2024 Next due 30 Sept 2025 8 months overdue
Confirmation Submitted 14 Oct 2024 Next due 15 Oct 2025 8 months overdue
Net assets £4M £133 2023 year on year
Total assets £4M £133 2023 year on year
Total Liabilities £0
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

Unit 16, Trade City Avro Way Brooklands Business Park Weybridge Surrey KT13 0YF England

Full company profile for MARCH MEDICAL LIMITED (05632950), a dissolved company based in Weybridge, England. Incorporated 23 Nov 2005. Activities of head offices. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type full
Next accounts 31 Dec 2024
Due by 30 Sept 2025 8 months overdue

Net Assets, Total Assets & Total Liabilities (2015–2023)

Cash in Bank

N/A

Net Assets

£3.75M

Increased by £133.00 (+0%)

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

5 Allotments 215,428 Shares £132k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
18 May 202031,572£20k£0.63
18 May 20209,471£8k£0.8
18 May 202096,613£99k£1.02
28 May 20199,472£6k£0.63
19 Jan 201168,300£6.83£0

Officers

Officers

1 active 2 resigned
Status
Patel, Janit VishnuprasadDirectorBritishEngland5622 Feb 2021Active

Shareholders

Shareholders (2)

Serb Ltd
100.0%
100
Serb Ltd
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Serb Ltd

United Kingdom

Active
Notified 18 May 2020
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Graham Alan March

Ceased 18 May 2020

Ceased

Carole Iris March

Ceased 18 May 2020

Ceased

Group Structure

Group Structure

MARCH MEDICAL LIMITED Current Company

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
17 Mar 2026GazetteGazette Dissolved Voluntary
24 Jun 2025CapitalCapital Statement Capital Company With Date Currency Figure
24 Jun 2025OfficersTermination of Collyer Bristow Secretaries Limited as director on 11 Jun 2025
23 Jun 2025InsolvencySolvency Statement dated 20/06/25
23 Jun 2025CapitalStatement by Directors
17 Mar 2026 Gazette

Gazette Dissolved Voluntary

24 Jun 2025 Capital

Capital Statement Capital Company With Date Currency Figure

24 Jun 2025 Officers

Termination of Collyer Bristow Secretaries Limited as director on 11 Jun 2025

23 Jun 2025 Insolvency

Solvency Statement dated 20/06/25

23 Jun 2025 Capital

Statement by Directors

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

2 months ago on 17 Mar 2026

Capital Statement Capital Company With Date Currency Figure

11 months ago on 24 Jun 2025

Termination of Collyer Bristow Secretaries Limited as director on 11 Jun 2025

11 months ago on 24 Jun 2025

Solvency Statement dated 20/06/25

11 months ago on 23 Jun 2025

Statement by Directors

11 months ago on 23 Jun 2025